Johnson & Johnson appears to exit LAA closure market, selling heart tech to new startup

Marketplace

Please login to access the CRTOnline.

Johnson & Johnson appears to exit LAA closure market, selling heart tech to new startup

Jaguar LAA, a new California-based medtech startup, has purchased key assets related to performing left atrial appendage (LAA) closure procedures from Johnson & Johnson.

ACC and AHA Guidance for Noncardiac Surgery Remains Unchanged

Temporary Active Fixation Leads in Transcatheter Aortic Valve Replacement Patients with Baseline Right Bundle Branch Block

Surgical Bailout During TAVR: A Contemporary Analysis of the Centers for Medicare and Medicaid Services Database

Multicenter Cohort Study Shows Long-Term Survival Benefits in Early Mitral Valve Surgery for MR

Valve-in-Valve TMVR Linked to Fewer Reinterventions, LVOT Obstructions vs Valve-in-Ring: Pooled Analysis

Drug-Coated Devices Put Patients With CLTI at Higher Risk for Amputation: SWEDEPAD-1 Post Hoc Analysis

Healthy Food for a Healthy Heart: ACC Cardiologists Discuss Nutrition and CVD in New Scientific Statement

Researchers Say Echocardiography Cutoffs for RV Dysfunction Are Valuable in Patients With Secondary TR

Study Suggests Radial Access Superior to Femoral Route for Secondary Use in TAVR Procedures

Frailty, Poor Physical Functioning Predict Later-Life CVD Events in ASPREE Case-Control Substudy

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Marketplace

Johnson & Johnson appears to exit LAA closure market, selling heart tech to new startup

Explore the Site

Stay Connected